Clinical characteristics and prognostic factors in brain abscess Authors: Khalid Bajunaid, Taghreed Al-Sinani, Omar Ibrahim Aljohani, Basim Almalki, Baland Kordi, Faisal AlRashdan, Ali Alhabib, Nawaf Aljehani, Saleh Salem Baeesa Published: 2026 ABSTRACT Background: Brain abscess remains a serious intracranial infection associated with substantial mortality and neurological disability, despite advances in neuroimaging, neurosurgery, and antimicrobial therapy. Recent data from the Middle East are limited, and the prognostic impact of readily available clinical and radiologic variables in this region remains poorly defined.Methods: We retrospectively analyzed data from consecutive patients with radiologically and clinically confirmed brain abscesses treated at two tertiary centers in Jeddah, Saudi Arabia, between 2010 and 2020. Demographic, clinical, radiological, and laboratory data were extracted from medical records using a standardized form. Functional outcomes at discharge were assessed using the modified Rankin Scale (mRS) and dichotomized as favorable (mRS 0–3) or unfavorable (mRS 4–6).Results: Thirty-four patients were included (mean age 30.9 years, standard deviation [SD] 21.0; 70.6% male). Single abscesses predominated (94.1%), most commonly located in the frontal (35.3%) and parietal (29.4%) lobes, with a mean abscess volume of 33.5 mL (SD 29.9). Microbiological yield was 44.1% overall; Group B Streptococcus was the most common organism identified in aspirate cultures (5/12 positive aspirates), and coagulase-negative Staphylococci predominated in positive blood cultures (3/6). At discharge, 24 (70.6%) patients had a favorable outcome, and 10 (29.4%) patients had an unfavorable outcome. Patients with favorable outcomes were younger than those with unfavorable outcomes (mean 25.4 vs. 44.0 years; P = 0.016), and age ≤30 years was significantly associated with favorable outcomes (P = 0.019). Lower Glasgow Coma Scale (GCS) at admission, particularly GCS <8, was strongly associated with unfavorable outcomes (P = 0.015). Abscess volume, lobar location, sex, nationality, and diabetes were not significantly related to outcomes.Conclusion: In this two-center Saudi cohort, approximately two-thirds of patients with brain abscess achieved favorable functional outcomes, comparable to those in recent international series. Older age and reduced level of consciousness at admission were the main variables associated with poor outcomes on univariable analysis, whereas abscess volume and location were not significant in this sample. These findings support the central role of simple bedside variables, age and admission GCS, in risk stratification and highlight the need for larger regional studies to validate prognostic models and evaluate long-term outcomes in Middle Eastern populations. INTRODUCTION A brain abscess is a serious intracranial infection that typically presents as a focal collection of pus within the brain parenchyma. In most cases, it arises from contiguous spread, hematogenous seeding, or following neurosurgical procedures. Advances in neuroimaging and antimicrobial agents have improved the diagnosis and management of such entities.[6,15] Mortality has significantly decreased over the past 60 years, from 50% to 60% to approximately 10–20%, owing to advancements in the current era; however, the disease still poses a challenge to clinicians because of the complexity of management and potential neurological sequelae.[3] Multiple studies have identified several predictors of poor outcome, including age, decreased level of consciousness at presentation, and intraventricular rupture, among other factors.[6] However, the strength and consistency of these associations vary between series, and most data originate from single-center cohorts in Europe and Asia, with limited representation from the Middle East and the Gulf region.[9-11,17] Saudi Arabia and the broader Middle East have experienced demographic and epidemiologic shifts, including rising rates of diabetes, which may influence the profile and outcomes of brain abscesses. As diabetes mellitus is known to impair immune function, particularly cellular immunity and neutrophil activity, which predisposes affected individuals to pyogenic infections, including brain abscess. Given the high prevalence of diabetes in Saudi Arabia (estimated at 18– 25% in adults), this comorbidity may represent a clinically relevant modifier of abscess susceptibility and outcomes in our population, warranting explicit evaluation in regional series. However, contemporary data from this region are scarce, and there is a particular lack of detailed analyses focusing on functional outcomes and their predictors in neurosurgical referral centers.[4,10,17] In this context, we conducted a retrospective multicenter study of patients with radiologically and clinically confirmed brain abscesses in Jeddah, Saudi Arabia. We aimed to describe the epidemiological and clinical characteristics, management, and outcomes of brain abscesses in our setting and identify factors associated with favorable versus poor functional outcomes. MATERIALS AND METHODS Study design and setting We conducted a retrospective two-center cohort study of consecutive patients with brain abscess managed at two tertiary neurosurgical centers in Jeddah, Saudi Arabia (King Abdulaziz University Hospital [KAUH] and King Fahad General Hospital [KFGH]) between January 2010 and December 2020. Both institutions are regional neurosurgical referral centers that serve Jeddah and the surrounding regions. The study period extended from January 2010 to December 2020, and all consecutive eligible cases during this period were included. This study was approved by the Biomedical Ethics Research Committee at King Abdulaziz University (reference no. 346– 22). The study was designed and reported in accordance with the strengthening the reporting of observational studies in epidemiology guidelines for cohort studies.[16] Eligibility criteria Patients were included in the study if they met one of the following criteria: positive microbiological culture from a surgical sample or radiological evidence on contrast-enhanced computed tomography (CT) and/or magnetic resonance imaging (MRI) consistent with a brain abscess. In cases without positive microbiological culture, the diagnosis of brain abscess was confirmed radiologically by the combination of (1) ring-enhancing lesion on contrast-enhanced CT or MRI with central restricted diffusion on diffusion-weighted imaging/apparent diffusion coefficient, and (2) compatible clinical context (fever, focal neurological deficit, or raised inflammatory markers). Cases with imaging features atypical for pyogenic abscess (e.g., irregular wall, necrotic tumor pattern, absence of restricted diffusion) were reviewed by a senior neuroradiologist and excluded if the diagnosis remained uncertain. Patients with intracranial empyema without parenchymal abscess or incomplete medical records lacking essential clinical or outcome data were excluded. We included all ages and recorded age as a continuous variable. Data collection and variables Data were collected from electronic and paper medical records using a standardized report form. The data were independently extracted by two investigators using a standardized, pre-designed form. Any discrepancies were resolved by consensus with a third senior author. This dual-extraction approach was applied to minimize information bias inherent to retrospective data collection. The extracted variables included demographics (age at diagnosis in years, sex, and nationality categorized as Saudi or non-Saudi), comorbidities and host factors (diabetes mellitus, hypertension, and immunocompromised status), and clinical characteristics (duration of symptoms before admission in days, Glasgow Coma scale (GCS) score on admission, and other presenting features such as headache, fever, seizures, or focal neurological deficit when available). Radiological characteristics comprised the number of abscesses (single or multiple), location, and abscess volume in milliliters. Abscess volume was calculated using the standard ellipsoid formula (0.5 × A × B × C), where A, B, and C represent the maximal diameters in three planes on CT or MRI, consistent with previous studies. Laboratory data included white blood cell count on admission and, when available, other routine biomarkers. Microbiological data included blood culture results and, where applicable, intraoperative aspirate culture results obtained during surgical drainage. Blood cultures were performed in 30/34 patients (88.2%), and aspirate cultures were obtained in 28/34 patients (82.4%); cultures were not performed in the remaining cases due to clinical decisions made at the treating team’s discretion or technical limitations. Culture-negative cases were retained in the analysis and classified as “no organism identified;” they were not excluded, as culture negativity is a recognized real-world finding in brain abscess management, particularly in patients who received antibiotics before sampling. Empirical broad-spectrum antibiotic therapy was initiated in all patients regardless of culture result and was subsequently tailored based on culture and sensitivity findings when available. Treatment and hospital course variables included hospital center (KAUH or KFGH) and duration of hospital stay in days. Outcome measures consisted of functional outcomes at hospital discharge, assessed using the modified Rankin scale (mRS). For analysis, outcomes were dichotomized as favorable (mRS 0–3) or poor (mRS 4–6), consistent with prior brain abscess and neurosurgical literature. In-hospital mortality was also recorded. Statistical analysis Continuous variables are expressed as mean and standard deviation (SD), and categorical variables are expressed as counts and percentages. Comparisons between the groups with favorable and poor outcomes were performed using the Mann–Whitney U test for continuous variables and the Chi-squared test or Fisher’s exact test, as appropriate, for categorical variables. A two-sided P < 0.05 was considered statistically significant. Owing to the limited sample size, we focused on univariable associations and treated the analysis as exploratory; therefore, multivariable regression was not performed. All analyses were performed using Statistical Package for Social Sciences (SPSS) Statistics for Windows ver.31 (IBM Corp. IBM SPSS Statistics for Windows, Version 31.0. Armonk, NY: IBM Corp). RESULTS Thirty-four patients with brain abscesses were included in this study. The mean age was 30.9 years (SD, 21.0), and most of the patients were men (70.6%). Two-thirds of the cases were managed at KFGH (64.7%), and one-third were managed at KAUH (35.3%). Diabetes was present in 11.8% of the patients, and 5.9% were classified as immunocompromised [Table 1]. Table 1:Patients demographics. Patients demographics. The mean duration of symptoms before presentation was 12.4 days (SD 8.7). The median GCS score on admission was 14 (interquartile range, 11–14), indicating that most of the patients presented with preserved or only mildly impaired consciousness. Single abscesses predominated (94.1%, 32/34). The frontal (35.3%), parietal (29.4%), and temporal (14.7%) lobes were the most frequently affected. The mean abscess volume was 33.5 mL (SD 29.9) [Tables 2 and 3]. Blood cultures were performed in 30/34 (88.2%) patients, of whom 6 (20.0%) yielded a positive result. The most common organisms identified in blood cultures were coagulase-negative Staphylococci (3/6), followed by Klebsiella spp. (2/6). Aspirate cultures were obtained in 28/34 (82.4%) patients; 12/28 (42.9%) were positive. Group B Streptococcus was the most frequently isolated organism in aspirate cultures (5/12), followed by Staphylococcus haemolyticus (2/12). Overall, at least one positive culture was obtained in 15/34 (44.1%) patients, while no organism was identified in 19/34 (55.9%). Culture positivity did not differ significantly between favorable and unfavorable outcomes. Table 2:Clinical presentation and abscess characteristics. Clinical presentation and abscess characteristics. Table 3:Factors associated with a favorable outcome. Factors associated with a favorable outcome. At discharge, 24 (70.6%) patients had a favorable outcome (mRS 0–3) and 10 (29.4%) had an unfavorable outcome (mRS 4–6). Patients with favorable outcomes were younger (mean 25.4 years, SD 20.6) than those with unfavorable outcomes (mean 44.0 years, SD 16.1; P = 0.016). When age was categorized, ≤30 years was significantly associated with a favorable outcome (70.3% vs. 20.0% in the poor-outcome group; P = 0.019) [Table 3]. Sex, nationality, and diabetes were not significantly associated with poor outcomes. In contrast, GCS at admission showed a strong relationship with prognosis: all patients with GCS <8 were in the unfavorable group (30% vs. 0%; P = 0.015), while higher GCS categories (8–12 and 13–15) were more frequent among those with favorable outcomes. Abscess location, length of hospital stay, and abscess volume did not differ significantly between outcome groups (P = 0.83, 0.125, and 0.82, respectively) [Table 3]. DISCUSSION This study explored cases of brain abscess at two neurosurgical centers in Saudi Arabia. Approximately two-thirds of patients with brain abscess achieved a favorable functional outcome at discharge (mRS 0–3), while nearly one-third had severe disability or death. These results are comparable to modern worldwide data, which report good functional outcomes in 60–75% of cases, with a mortality rate of 5–15% in brain abscess cases.[1,5] These results indicate outcomes at Saudi tertiary centers that are in line with international experience. A Chinese cohort of brain abscess cases (n = 57) reported 75.4% good outcomes and 3.5% mortality. In contrast, a stereotactic aspiration series (n = 120) showed 89.2% good outcomes and 2.5% mortality. In the study by Brouwer et al., the pooled mortality rate was 20%, with a substantial decline in fatalities in the early 2000 cohort, reaching 10%.[4,5,10,18] In our study, we identified older age and decreased level of consciousness at admission as variables significantly associated with poor outcomes on univariable analysis. Patients in the unfavorable group were significantly older (>30 years), and this was associated with worse outcomes. These results are in line with those of other studies, which have reported older age as a predictor of mortality.[8] The median age of patients with favorable outcomes in our cohort was 25.4 years, compared with a median age of 44 years in the unfavorable group. The Danish Nationwide Population-Based Cohort Study reported age as a factor for poor outcome and age >65 years as an independent factor for mortality.[1-3] Darlow et al. and Landriel et al. have reported age as a significant factor for poor outcomes and mortality.[7,14] A low GCS score at admission has been reported as a significant factor for an unfavorable outcome in previous studies. Cronin et al. reported low GCS and altered mental status at admission as predictors of requiring surgical intervention and mortality.[6] Similarly, Bodilsen et al. and Muzumdar et al. showed worse prognoses among patients with lower initial GCS scores. Our study findings were similar, as we showed that patients with a GCS of <8 at presentation showed an unfavorable outcome compared to those with an initial GCS of 13–15.[3,15] Our study did not find a significant association between abscess location, volume, or length of hospital stay and functional outcomes. The overall mean abscess volume in our study was 33.5 mL (SD, 29.9). When the two groups were compared, the mean volumes were similar in the favorable and unfavorable groups (35.0 mL vs. 30.1 mL; P = 0.82). Several studies have suggested that larger abscess size or volume increases the risk of complications, intraventricular rupture, or poor outcomes, particularly above thresholds such as 2.5 cm in diameter or 20 mL in volume.[5,6,12] The study presented here adds to the data from the Gulf and Middle Eastern regions, which lack more recent data on brain abscess pathology. Early work from Saudi Arabia by Ibrahim et al. discussed 26 cases of brain abscess with a mortality rate of 15.3% and a high volume of focal neurological deficits from the early 1990s.[9,13] While another central region and the Asser region case series reported similar mortality, ranging from 15% to 20%.[11] The study by Waked et al. from Lebanon underlines that brain abscess continues to be a serious illness in the Middle East that poses serious consequences to patients.[17] Our study suggests the need for a multidisciplinary, protocol-driven management of such pathologies to improve outcomes and decrease mortality. In a region where diabetes prevalence is rising, a multidisciplinary approach to such pathologies may assist in improving favorable outcomes. Several limitations of our current study include its retrospective nature and small sample size, which would restrict its statistical power. In addition, from a statistical standpoint, the analysis is limited to univariable comparisons. Multivariable logistic regression was not performed due to the small sample size (n = 34) and the limited number of unfavorable outcome events (n = 10). In addition, the study was conducted in two tertiary neurosurgical centers, which could limit its generalizability to primary and non-referral centers. Despite these limitations, our study provides updated data from the Middle East region and shows that age and GCS at admission are clinically relevant variables associated with outcome in this cohort. CONCLUSION In our study, we observed that the majority of patients with brain abscess achieved a favorable functional outcome at discharge, with overall results comparable to those reported in recent European and Asian cohorts. Our results show that older age and level of consciousness at presentation were significantly associated with unfavorable outcomes. These findings demonstrate that neurological examination and the GCS remain important components of risk assessment and should be embedded in local management protocols, alongside timely management of such patients. Our data contribute to the region-specific evidence from the Middle East and call for large multicenter, prospective studies in the future.